Nanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies
EU regulator to decide on one-shot J&J vaccine next week
2 March 2021Ask the Pediatrician: Is it safe to travel over spring break this year?
2 March 2021Nanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies
Researchers from Cleveland Clinic’s Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.
